INVO Profile
INVO Bioscience, Inc., headquartered in Sarasota, Florida, operates as a leading commercial-stage fertility company specializing in innovative assisted reproductive technology solutions offered globally. Established in 2007, the company has pioneered the development and commercialization of the INVOcell, its flagship medical device designed to facilitate fertilization and early embryo development within the female reproductive system.
The INVOcell represents a revolutionary approach to fertility treatment, providing a more natural and patient-friendly alternative to traditional in vitro fertilization (IVF) methods. By allowing fertilization and embryo incubation to occur inside the woman's body (in vivo), the INVOcell enhances the physiological conditions for embryo development, potentially improving success rates and patient outcomes.
In addition to its innovative technology, INVO Bioscience, Inc. offers comprehensive support and training programs for healthcare providers worldwide. The company collaborates closely with fertility clinics and reproductive specialists to integrate the INVOcell system into clinical practice, ensuring consistent delivery of high-quality fertility care.
Committed to advancing reproductive healthcare, INVO Bioscience, Inc. continues to expand its product offerings and research initiatives. The company invests in ongoing clinical studies and regulatory compliance to further validate the efficacy and safety of its technologies, aiming to broaden access to affordable fertility treatments and improve the overall patient experience.
|
